Netoglitazone

OC000459 is a potent and selective D prostanoid receptor 2 (DP2) antagonist with IC50 of 13 nM.

OC000459 is a potent and selective D prostanoid receptor 2 (DP2) antagonist with IC50 of 13 nM.

p27 is an important regulator of cell cycle progression, involved in G1 arrest. It is a potent inhibitor of cyclin E1- and cyclin A-CDK2 complexes and a positive regulator of cyclin D-dependent kinases such as CDK4.

p27 is an important regulator of cell cycle progression, involved in G1 arrest. It is a potent inhibitor of cyclin E1- and cyclin A-CDK2 complexes and a positive regulator of cyclin D-dependent kinases such as CDK4.

Antigen: phosphopeptide corresponding to amino acid residues surrounding phospho-Thr180 and phospho-Tyr182 of rat p38 MAPK Host: rabbit Cross Reactivity: (+) human p38 MAPK Application(s): WB p38 MAPK is activated by both inflammatory cytokines and

PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM, ~1000-fold selective for FGFR1 than PDGFR and c-Src.Potent inhibitor of FGF and VEGF (Flt/Flk) receptors.

PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM, ~1000-fold selective for FGFR1 than PDGFR and c-Src.Potent inhibitor of FGF and VEGF (Flt/Flk) receptors.

PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM, ~1000-fold selective for FGFR1 than PDGFR and c-Src.Potent inhibitor of FGF and VEGF (Flt/Flk) receptors.

InformationPD318088 is a non-ATP competitive allostericMEK1/2inhibitor, binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site.In vitroPD318088 is a small-molecule inhibitor of MEK1/2, which is an

PDC31 (THG113.31: ILGHXDYK) is an allosteric and non-competitive inhibitor of FP Prostaglandin Receptor . PDC31 is the D-amino acid-based oligopeptide, is used for smooth muscle contractile agent. PDC31 decreases the strength and duration of uterine

PDC31 (THG113.31: ILGHXDYK) is an allosteric and non-competitive inhibitor of FP Prostaglandin Receptor . PDC31 is the D-amino acid-based oligopeptide, is used for smooth muscle contractile agent. PDC31 decreases the strength and duration of uterine

General description The PDGFs are stored in platelet &#945:-granules and are released upon platelet activation. Two distinct signaling receptors used by PDGFs have been identified and named PDGFR-&#945: and PDGFR-&#946:.